Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Akhil Johri is Director at Boeing. OQRO lists 5 transactions filed with the SEC under this name, the latest on Nov 18, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
2
Akhil Johri bought shares on the open market in 2026 across 2 companies. Sales in 5 of the 16 years since 2011.
Akhil Johri reported 1 open-market purchase and 11 sales since 2011; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $500K1×1 trade | — |
| 2019 | — | $1.82M3×3 trades |
| 2018 | — | $1.27M2×2 trades |
| 2017 | — | $970K2×2 trades |
| 2016 | — | $230K1×1 trade |
| 2011 | — | $200K3×3 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
BoeingBA
4 disclosures · Jan 2026 – Nov 2026 · 1 bought
Nov 17, 2026Bought~$500Kdisclosed Nov 18
DetailsOfficial recordJul 1, 2026406disclosed Jul 6
DetailsOfficial recordApr 1, 2026428disclosed Apr 3
DetailsOfficial recordJan 2, 2026400disclosed Jan 6
DetailsOfficial recordNov 12, 20261disclosed Nov 16
DetailsOfficial recordAs of the latest filing on , Akhil Johri reported holding 22,869 shares of Cardinal Health (CAH), worth about $6.36M at the last close of $278 (Nov 18, 2026). Holdings are also on file at Boeing (BA); together they are worth about $6.88M. In the last 12 months, Akhil Johri bought $500K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Cardinal Health CAH | 22,869 | 23K direct | $278 | $6.36M | Nov 12, 2026 |
| Boeing BA | 3,150 | 3,150 direct | $163 | $513K | Nov 17, 2026 |
Is this Akhil Johri’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
On the latest SEC Form 4, dated Nov 12, 2026, Akhil Johri reported holding 22,869 shares of Cardinal Health (CAH). At the last close of $278 on Nov 18, 2026, that is about $6.36M. This is the stake disclosed in filings, not a net worth.
No public filing gives Akhil Johri's net worth. What SEC Form 4 shows is the stock stake: 22,869 shares of Cardinal Health (CAH), about $6.36M at the last close, plus holdings in 1 other company, about $6.88M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Akhil Johri reported 1 open-market purchase worth $500K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Akhil Johri bought shares on the open market in 2026 across 2 companies. Sales in 5 of the 16 years since 2011.
In SEC filings since 2011: the latest open-market purchase is from 2026; the latest open-market sale is from 2019.
2 companies: Boeing (BA, 2026), RTX (RTX, 2011–2019).
Akhil Johri reported 0 open-market purchases and 11 sales here, 2011 to 2019.
Akhil Johri reported 1 open-market purchase and 0 sales here, 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.